E-resources
-
Yoshinori Tsubakimoto
Journal of Atherosclerosis and Thrombosis, 2021, Volume: 28, Issue: 11Journal Article
In general, patients with peripheral arterial disease (PAD), including asymptomatic subjects, remain to be at a high risk of cardiovascular (CV) events and mortality. A recent meta-analysis also reported a 5-year cumulative CV mortality of 13% in PAD patients regardless of symptoms. In addition, the REACH registry has reported that PAD patients with atrial fibrillation (AF) have a worse prognosis than patients with PAD alone. It goes without saying that revascularization for PAD improves walking distance and/or symptoms such as claudication, but does not improve the prognosis of patients. Therefore, strict risk management is recommended to reduce the risk of future cardiovascular events.
